Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


India Pharma Industry Objects To Plan For Increasing Drug Exports

This article was originally published in PharmAsia News

Executive Summary

India's pharmaceutical industry is highly critical of a government proposal to increase drug exports with a series of incentives to various firms. The head of the Indian Pharmaceutical Alliance, which represents the industry, said the plan could be counter-productive because it relies on funding initiatives for firms merely registering products with the government. The Department of Pharmaceuticals had proposed funding by venture capitalists and initiatives such as tax exemptions, import duty waivers and protection for clinical test data. (Click here for more



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts